American Portfolios Advisors Eli Lilly & CO Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, American Portfolios Advisors holds 16,811 shares of LLY stock, worth $15.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

16,811

Holding current value

$15.2 Million

% of portfolio

0.23%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$296.48 - $337.87 $4.98 Million - $5.68 Million	16,811 New	16,811 $5.44 Billion
Q2 2022 Mar 20, 2023	SELL	$278.73 - $327.27 $81,667 - $95,890	-293 Reduced 1.74%	16,518 $5.36 Billion
Q1 2022 Mar 21, 2023	BUY	$234.69 - $291.66 $50,458 - $62,706	215 Added 1.28%	17,026 $4.88 Billion
Q4 2021 Mar 21, 2023	SELL	$224.85 - $279.04 $87,691 - $108,825	-390 Reduced 2.32%	16,421 $4.54 Billion
Q3 2021 Mar 22, 2023	SELL	$221.6 - $272.71 $454,058 - $558,782	-2,049 Reduced 12.19%	14,762 $3.41 Billion

Q2 2021 Mar 22, 2023	SELL	$180.55 - $233.54 $371,571 - $480,625	-2,058 Reduced 12.24%	14,753 $3.39 Billion
Q1 2021 Mar 22, 2023	SELL	$164.32 - $212.72 $346,057 - $447,988	-2,106 Reduced 12.53%	14,705 $2.75 Billion
Q4 2020 Mar 22, 2023	SELL	$130.46 - $172.63 $411,862 - $544,992	-3,157 Reduced 18.78%	13,654 $2.31 Billion
Q3 2020 Mar 22, 2023	SELL	$146.22 - $169.13 $414,533 - $479,483	-2,835 Reduced 16.86%	13,976 $2.07 Billion
Q2 2020 Mar 24, 2023	BUY	$136.42 - $164.18 $243,236 - $292,732	1,783 Added 13.61%	14,879 $2.44 Billion
Q1 2020 Mar 24, 2023	SELL	$119.05 - $147.35 $442,270 - $547,405	-3,715 Reduced 22.1%	13,096 $1.82 Billion
Q4 2019 Mar 24, 2023	SELL	$106.92 - $132.43 $248,802 - $308,164	-2,327 Reduced 13.84%	14,484 $1.9 Billion
Q3 2019 Mar 24, 2023	BUY	$106.79 - $116.16 $48,696 - $52,968	456 Added 3.22%	14,616 $1.63 Billion
Q2 2019 Mar 24, 2023	SELL	$110.79 - $129.32 $293,704 - $342,827	-2,651 Reduced 15.77%	14,160 $1.57 Billion
Q1 2019 Mar 24, 2023	BUY	$111.31 - $131.02 $660,958 - $777,996	5,938 Added 36.44%	22,235 $2.89 Billion
Q4 2018 Mar 24, 2023	BUY	$105.9 - $118.64 $165,204 - $185,078	1,560 Added 10.59%	16,297 $1.89 Billion
Q3 2018 Mar 24, 2023	SELL	$85.86 - $107.31 $178,073 - $222,560	-2,074 Reduced 12.34%	14,737 $1.58 Billion
Q2 2018 Mar 24, 2023	BUY	$75.7 - $86.88 $11,203 - $12,858	148 Added 0.94%	15,878 $1.35 Billion
Q1 2018 Mar 24, 2023	SELL	$74.21 - $87.6 $80,221 - $94,695	-1,081 Reduced 6.43%	15,730 $1.22 Billion
Q4 2017 Mar 24, 2023	SELL	$81.94 - $87.89 $262,863 - $281,951	-3,208	13,603 $1.15 Billion

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Eli Lilly & CO Transaction History